<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-pharmaceuticals-13-00464">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Boger</surname>
    <given-names>D.L.</given-names>
   </name>
   <name>
    <surname>Fecik</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Patterson</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Miyauchi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Patricelli</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Cravatt</surname>
    <given-names>B.F.</given-names>
   </name>
  </person-group>
  <article-title>Fatty acid amide hydrolase substrate specificity</article-title>
  <source>Bioorganic Med. Chem. Lett.</source>
  <year>2000</year>
  <volume>10</volume>
  <fpage>2613</fpage>
  <lpage>2616</lpage>
  <pub-id pub-id-type="doi">10.1016/S0960-894X(00)00528-X</pub-id>
 </element-citation>
</ref>
